[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-343517-en":3,"doc-seo-343517-105":51,"detail-sidebar-cat-0-en-105":116},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"doc_content":15,"file_id":16,"file_url":17,"file_type":18,"file_size":19,"view_count":20,"is_deleted":4,"is_public":21,"is_downloadable":21,"audit_status":21,"page_count":22,"language":23,"language_code":24,"site_id":25,"html_lang":24,"table_of_contents":26,"faqs":27,"seo_title":28,"seo_description":14,"update_tm":29,"read_time":30,"preview_page_count":31,"preview_urls":32},343517,687197207057,"Sage","https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0",8,"Research & Report","Comorbidity burden on mortality in patients with systemic sclerosis - Original research - Abstract","Systemic sclerosis is a serious, life-threatening autoimmune tissue disease where a substantial share of mortality is driven by comorbid conditions. This retrospective, single-centre observational study mapped the prevalence of 14 predefined comorbidities and analyzed their relationship to mortality, including demographic features, vital statistics, and organ involvement. Survival curves used Kaplan-Meier methods, followed by Cox regression for multivariate assessment in 400 participants (74 deaths).","Systemic sclerosis  \nTo cite: Fauthoux T, Brisou D, Lazaro E, et al. Comorbidity burden on mortality inpatients with systemic sclerosis. RMD Open 2024;10:e004637 . doi:10 . 1136/ rmdopen-2024-004637  \n► Additional supplemental material is published online only. To view, please visit the journal online ([https://doi.org/10.1136/](https://doi.org/10.1136/)[ ](https://doi.org/10.1136/)[rmdopen-2024-004637](rmdopen-2024-004637)) .  \nReceived 9 June 2024 Accepted 5 October 2024  \n© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.  \n1Médecine Interne, Hopital Saint-Antoine, Paris, France 2Pôle Biologie et Pathologie, CHU de Bordeaux, Bordeaux, France 3CHU de Bordeaux, Bordeaux, France  \n4Dermatology, CHU de Bordeaux, Bordeaux, France  \n5Internal Medicine Department, CHU de Bordeaux, Bordeaux, France  \n6CIRID, UMR CNRS-5164, ImmunoConcEpT, CHU de Bordeaux, Bordeaux, France 7Service de Rhumatologie, CHU de Bordeaux, Bordeaux, France 8Rhumatologie, CHU de Bordeaux, Bordeaux, France  \nCorrespondence to  \nDr Thomas Fauthoux; [thomas.fauthoux@aphp.fr](thomas.fauthoux@aphp.fr)  \nORIGINAL RESEARCH  \nComorbidity burden on mortality inpatients with systemic sclerosis  \nThomas Fauthoux  ,1 Damien Brisou,2 Estibaliz Lazaro,3 Julien Seneschal,4 Joel Constans,3 Sophie Skopinski,3 Pierre Duffau  ,5 Elodie Blanchard,3 Cécile Contin-Bordes  ,6 Thomas Barnetche  ,7 Marie-Elise Truchetet  8  \nABSTRACT  \nIntroduction Systemic sclerosis (SSc) is a serious lifethreatening tissue disease. A significant aspect of its mortality arises from comorbid conditions. Our study aimed at mapping out the prevalence of these comorbidities and their relation to mortality, thus creating a ‘comorbidome’. Methods In our retrospective, single-centre observational study, we recorded each patient’s data, including demographic informations, vital stats and SSc-related organ involvement, along with the presence or absence of 14 predefined comorbidities. We also documented the dates of their initial and most recent visits. To construct survival curves, we used the Kaplan-Meier method, followed by a Cox regression model for multivariate analysis.  \nResults Our study involved 400 participants, 74 of whom unfortunately passed away. It is important to note that three specific comorbidities showed significant correlation to mortality: neoplasia, cardiovascular diseases and polypharmacy, as well as two SSc-specific organ involvements (lung and cardiac) .  \nConclusion Our research led to the successful creation of the SSc comorbidome. Comorbidities are a major concern for patients suffering from SSc, particularly cardiovascular diseases and neoplasms. Our study highlights the effects of polypharmacy. The resultant comorbidome offers a comprehensive and analytical perspective on this complex issue and underscores the inter-relatedness of the data. Our study, however, was limited by a small sample size. Therefore, to confirm our findings, validation on a larger scale is necessary. This could potentially contribute to the creation of a future mortality scoring tool.  \nINTRODUCTION  \nSystemic sclerosis (SSc) is a rare, complex, autoimmune disease marked by an overproduction of the extracellular matrix in the skin and internal organs, leading to dysfunction.1 It appears to arise from two combined phenomena: immune system dysregulation, signified by immunological deposits in tissues and circulating auto-antibodies, and microvascular injuries, coupled with endothelial dysfunction. These injuries manifest as either scarcity or abnormal proliferation of capillaries, depending on the tissue involved.2  \nWHAT IS ALREADY KNOWN ON THIS TOPIC  \n\n| ⇒ Systemic sclerosis (SSc) can be lethal, with comorbidities worsening mortality in fragile, intensively treated patients.\u003Cbr>WHAT THIS STUDY ADDS |\n| --- |\n| ⇒ This study evaluated the comorbidity profiles of patients with SSc, alongside demographic and disease-spe","cbCaimF9UD04loI0","https://ap.wps.com/l/cbCaimF9UD04loI0","pdf",945795,6,1,9,"English","en",105,"# Abstract\n## Introduction\n## What is already known on this topic\n## What this study adds\n## How this study might affect research, practice or policy\n## Background and related literature","[{\"question\":\"What was the study’s main aim regarding systemic sclerosis mortality?\",\"answer\":\"To map the prevalence of comorbidities in patients with systemic sclerosis and determine how these comorbidities relate to mortality, forming a “comorbidome.”\"},{\"question\":\"How were comorbidities and outcomes analyzed in the study?\",\"answer\":\"A retrospective, single-centre approach recorded demographic data, vital statistics, SSc-related organ involvement, and the presence or absence of 14 predefined comorbidities. Survival curves used Kaplan-Meier, and multivariate effects were assessed with Cox regression.\"},{\"question\":\"Which comorbidities and organ involvements were associated with mortality?\",\"answer\":\"Neoplasia, cardiovascular diseases, and polypharmacy showed significant correlations with mortality, along with two SSc-specific organ involvements: lung and cardiac involvement.\"}]","Comorbidity burden on mortality in patients with systemic sclerosis - Original research - Abstract | PDF",1790051363,23,4,[33,37,42,47],{"page_no":21,"url":34,"width":35,"height":36},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/965d000fcb87a16de23e44a6d762a954.webp",983,1310,{"page_no":38,"url":39,"width":40,"height":41},2,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5cd15f9b3cc9678295d1ece9a50dfcd6.webp",982,1309,{"page_no":43,"url":44,"width":45,"height":46},3,"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/27759f2993b35b285fad5173e00b4e8c.webp",981,1308,{"page_no":31,"url":48,"width":49,"height":50},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4caf14c4545e1e15628227a61657bcea.webp",980,1306,{"code":4,"msg":52,"data":53},"ok",{"site_id":25,"language":24,"slug":54,"title":13,"keywords":55,"description":14,"schema_data":56,"social_meta":110,"head_meta":112,"extra_data":114,"updated_unix":115},"comorbidity-burden-on-mortality-in-patients-with-systemic-sclerosis-original-research-abstract","",{"@graph":57,"@context":109},[58,72,92],{"@type":59,"itemListElement":60},"BreadcrumbList",[61,65,68,70],{"item":62,"name":63,"@type":64,"position":21},"https://docshare.wps.com","Home","ListItem",{"item":66,"name":67,"@type":64,"position":38},"https://docshare.wps.com/document/","Document",{"item":69,"name":12,"@type":64,"position":43},"https://docshare.wps.com/document/research-report/",{"item":71,"name":13,"@type":64,"position":31},"https://docshare.wps.com/document/comorbidity-burden-on-mortality-in-patients-with-systemic-sclerosis-original-research-abstract/343517/",{"url":71,"name":13,"@type":73,"image":74,"author":79,"headline":13,"publisher":81,"fileFormat":84,"inLanguage":24,"description":14,"dateModified":85,"datePublished":86,"encodingFormat":84,"isAccessibleForFree":87,"interactionStatistic":88},"DigitalDocument",{"url":75,"@type":76,"width":77,"height":78},"https://docshare.wps.com/thumbnails/comorbidity-burden-on-mortality-in-patients-with-systemic-sclerosis-original-research-abstract/343517.png","ImageObject",300,407,{"name":9,"@type":80},"Person",{"url":62,"name":82,"@type":83},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":89,"interactionType":90,"userInteractionCount":20},"InteractionCounter",{"@type":91},"ViewAction",{"@type":93,"mainEntity":94},"FAQPage",[95,101,105],{"name":96,"@type":97,"acceptedAnswer":98},"What was the study’s main aim regarding systemic sclerosis mortality?","Question",{"text":99,"@type":100},"To map the prevalence of comorbidities in patients with systemic sclerosis and determine how these comorbidities relate to mortality, forming a “comorbidome.”","Answer",{"name":102,"@type":97,"acceptedAnswer":103},"How were comorbidities and outcomes analyzed in the study?",{"text":104,"@type":100},"A retrospective, single-centre approach recorded demographic data, vital statistics, SSc-related organ involvement, and the presence or absence of 14 predefined comorbidities. Survival curves used Kaplan-Meier, and multivariate effects were assessed with Cox regression.",{"name":106,"@type":97,"acceptedAnswer":107},"Which comorbidities and organ involvements were associated with mortality?",{"text":108,"@type":100},"Neoplasia, cardiovascular diseases, and polypharmacy showed significant correlations with mortality, along with two SSc-specific organ involvements: lung and cardiac involvement.","https://schema.org",{"og:url":71,"og:type":111,"og:title":13,"og:site_name":82,"og:description":14},"article",{"robots":113,"canonical":71},"index,follow",{"doc_id":7,"site_id":25},1790858516,{"code":4,"msg":5,"data":117},[118,122,126,130,135,139,144,147,151,154,158],{"id":21,"doc_module":4,"doc_module_name":67,"category_name":119,"show_sort_weight":120,"slug":121},"Story & Novel",90,"story-novel",{"id":38,"doc_module":4,"doc_module_name":67,"category_name":123,"show_sort_weight":124,"slug":125},"Literature",80,"literature",{"id":31,"doc_module":4,"doc_module_name":67,"category_name":127,"show_sort_weight":128,"slug":129},"Exam",70,"exam",{"id":131,"doc_module":4,"doc_module_name":67,"category_name":132,"show_sort_weight":133,"slug":134},5,"Comic",60,"comic",{"id":20,"doc_module":4,"doc_module_name":67,"category_name":136,"show_sort_weight":137,"slug":138},"Technology",50,"technology",{"id":140,"doc_module":4,"doc_module_name":67,"category_name":141,"show_sort_weight":142,"slug":143},7,"Healthcare",40,"healthcare",{"id":11,"doc_module":4,"doc_module_name":67,"category_name":12,"show_sort_weight":145,"slug":146},30,"research-report",{"id":22,"doc_module":4,"doc_module_name":67,"category_name":148,"show_sort_weight":149,"slug":150},"Religion & Spirituality",20,"religion-spirituality",{"id":149,"doc_module":4,"doc_module_name":67,"category_name":152,"show_sort_weight":149,"slug":153},"World Cup","world-cup",{"id":155,"doc_module":4,"doc_module_name":67,"category_name":156,"show_sort_weight":155,"slug":157},10,"Lifestyle","lifestyle",{"id":159,"doc_module":4,"doc_module_name":67,"category_name":160,"show_sort_weight":131,"slug":161},19,"General","general"]